EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of KHS-101 as a Transcription Factor EB Activator to Promote α-Synuclein Degradation

Haizhen Zhu, Anqi Ren, Ting Li, Tao Zhou iD, Ailing Li, Xin Pan iD, Liang Chen, Jiayi Chen iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27020905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Haizhen Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanhu Laboratory, State Key Laboratory of Biomedical Analysis (SKLBA, Formerly Known as National Center of Biomedical Analysis, NCBA), Beijing 100039…. Hauptthemen laut MEDLINE: alpha-Synuclein, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative disorders are increasingly linked to a progressive decline in lysosomal function. Activating Transcription Factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy, has therefore emerged as a promising therapeutic strategy to enhance cellular clearance in these conditions. In this study, we identified KHS-101 as a novel TFEB activator through a high-throughput screen of blood–brain-barrier-permeable small molecules. We demonstrated that KHS-101 promotes TFEB nuclear translocation, enhances lysosomal biogenesis and proteolytic activity, and increases autophagic flux. Furthermore, KHS-101 significantly accelerates the degradation of pathogenic A53T mutant α-synuclein in a cellular model of Parkinson’s disease, suggesting its potential to mitigate α-synuclein-mediated proteotoxicity and hold neuroprotective potential. Our findings identify KHS-101 as a potent TFEB activator and highlight the therapeutic potential of modulating the autophagy-lysosomal pathway for treating Parkinson’s disease and related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsHumansAutophagyLysosomesProteolysisParkinson DiseaseAnimals

Stichwörter der Autor:innen

KHS-101Parkinson’s diseaseTFEBautophagy–lysosome pathwaylysosome degradationα-synuclein

Substanzen

alpha-SynucleinBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsTFEB protein, human

Autor:innen und Institutionen

  • Nanhu Laboratory, State Key Laboratory of Biomedical Analysis (SKLBA, Formerly Known as National Center of Biomedical Analysis, NCBA), Beijing 100039, China.

ORCID-Profile: Tao Zhou, Xin Pan, Jiayi Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhu, H., Ren, A., Li, T., Zhou, T., Li, A., Pan, X., Chen, L., & Chen, J. (2026). Identification of KHS-101 as a Transcription Factor EB Activator to Promote α-Synuclein Degradation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020905

Vancouver

Zhu H, Ren A, Li T, Zhou T, Li A, Pan X, et al. Identification of KHS-101 as a Transcription Factor EB Activator to Promote α-Synuclein Degradation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020905

BibTeX
@article{Zhu2026,
  author = {Zhu, Haizhen and Ren, Anqi and Li, Ting and Zhou, Tao and Li, Ailing and Pan, Xin and Chen, Liang and Chen, Jiayi},
  title = {Identification of KHS-101 as a Transcription Factor EB Activator to Promote α-Synuclein Degradation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27020905}
}
Kostenlos starten →